BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25060307)

  • 1. Genetic similarities between tobacco use disorder and related comorbidities: an exploratory study.
    de Viron S; Morré SA; Van Oyen H; Brand A; Ouburg S
    BMC Med Genet; 2014 Jul; 15():85. PubMed ID: 25060307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder.
    McEachin RC; Saccone NL; Saccone SF; Kleyman-Smith YD; Kar T; Kare RK; Ade AS; Sartor MA; Cavalcoli JD; McInnis MG
    BMC Med Genet; 2010 Jan; 11():14. PubMed ID: 20102619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders.
    Pizzo de Castro MR; Vargas Nunes SO; Guembarovski RL; Ariza CB; Oda JM; Vargas HO; Piccoli de Melo LG; Watanabe MA; Berk M; Maes M
    J Affect Disord; 2015 Feb; 172():347-54. PubMed ID: 25451436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.
    Vargas Nunes SO; Pizzo de Castro MR; Moreira EG; Guembarovski RL; Barbosa DS; Vargas HO; Piccoli de Melo LG; Bortolasci CC; Watanabe MA; Dodd S; Berk M; Maes M
    Neurosci Lett; 2015 Jan; 585():132-7. PubMed ID: 25445355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder.
    Nunes SO; Piccoli de Melo LG; Pizzo de Castro MR; Barbosa DS; Vargas HO; Berk M; Maes M
    J Affect Disord; 2015 Feb; 172():55-62. PubMed ID: 25451396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Drug Alcohol Depend; 2019 Nov; 204():107557. PubMed ID: 31557578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco and alcohol use disorders: Evaluating multimorbidity.
    MacLean RR; Sofuoglu M; Rosenheck R
    Addict Behav; 2018 Mar; 78():59-66. PubMed ID: 29127785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco use disorder: Prevalence, associated factors and its influence on quality of life among patients on methadone assisted treatment.
    Moey CH; Yee A; Muhamud Kayat SB
    J Addict Dis; 2020; 38(3):263-270. PubMed ID: 32329412
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlates of Concurrent Morbid Obesity and Tobacco Use Disorder Nationally in the Veterans Health Administration.
    Roberts W; Rosenheck RA
    J Dual Diagn; 2020 Oct; 16(4):373-381. PubMed ID: 32866073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions.
    Lin JC; Karno MP; Grella CE; Ray LA; Liao DH; Moore AA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1356-63. PubMed ID: 24021218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic scores for tobacco use provide insights into systemic health risks in a diverse EHR-linked biobank in Los Angeles.
    Venkateswaran V; Boulier K; Ding Y; Johnson R; Bhattacharya A; Pasaniuc B
    Transl Psychiatry; 2024 Jan; 14(1):38. PubMed ID: 38238290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults.
    Kahle EM; Veliz P; McCabe SE; Boyd CJ
    Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends analysis of surgical procedures for cervical degenerative disc disease and myelopathy in patients with tobacco use disorder.
    Grisdela P; Buser Z; D'Oro A; Paholpak P; Liu JC; Wang JC
    Eur Spine J; 2017 Sep; 26(9):2386-2392. PubMed ID: 28488093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of Alcohol, Tobacco, and Drug Use Disorders Among Sexual Minority Individuals and Their "Not Sure" Counterparts.
    Boyd CJ; Veliz PT; Stephenson R; Hughes TL; McCabe SE
    LGBT Health; 2019 Jan; 6(1):15-22. PubMed ID: 30638419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between regular cocaine use, with and without tobacco co-use, and adverse cardiovascular and respiratory outcomes.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Drug Alcohol Depend; 2020 Sep; 214():108136. PubMed ID: 32623147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III.
    Fields LJ; Roberts W; Schwing I; McCoy M; Verplaetse TL; Peltier MR; Carretta RF; Zakiniaeiz Y; Rosenheck R; McKee SA
    Drug Alcohol Depend Rep; 2023 Jun; 7():100162. PubMed ID: 37159814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):454-461. PubMed ID: 31743053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument.
    Siegel SD; Laurenceau JP; Hill N; Bauer AM; Flitter A; Ziedonis D; Stevens N; Hosie Quinn M; Leone F; Beidas R; Kimberly J; Schnoll RA
    Addict Behav; 2021 Mar; 114():106735. PubMed ID: 33248743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.